Endometriosis Linked to Higher Chronic Endometritis Rates in Infertile Patients, Study Shows

Endometriosis and chronic endometritis frequently overlap in infertile patients, according to retrospective data published on October 30, 2026, in Medicine. Researchers evaluated 250 patients with laparoscopically confirmed endometriosis alongside a control group of 750 patients with tubal-factor infertility.

The analysis showed a much higher detection rate of chronic endometritis in the endometriosis group than in the control population. All participants underwent hysteroscopy, laparoscopy, and endometrial biopsy to confirm diagnoses. Chronic endometritis was identified using cluster of differentiation 38 and cluster of differentiation 138 immunohistochemistry.

Within the endometriosis cohort, chronic endometritis prevalence varied markedly by disease stage. Patients with moderate-to-severe disease showed a prevalence of 45.1%, compared with 24.0% in those with mild disease.

Clinical Factors Tied to Concurrent Endometritis

Several variables showed independent associations with concurrent chronic endometritis in patients with endometriosis. These factors included moderate-to-severe disease staging, repeated intrauterine procedures, an infertility duration of three years or longer, chronic pelvic pain, and higher gravidity.

Conventional gynecological evaluations often prioritize a single pelvic disorder. This diagnostic approach risks overlooking concurrent pathologies because chronic endometritis presents with mild, nonspecific symptoms that classic endometriosis features can easily mask.

The study authors said that this diagnostic oversight can lead to missed dual diagnoses, incomplete therapeutic intervention, and elevated recurrence risks. Standardized simultaneous evaluations for both conditions remain uncommon in routine clinical practice.

Endometriosis Linked to Higher Chronic Endometritis Rates in Infertile Patients, Study Shows
Photo: ovid.com

Endometriosis Group Shows Lower Pregnancy Rates and Higher Loss

At the one-year mark, reproductive outcomes diverged between the study cohorts. The endometriosis group recorded a lower clinical pregnancy rate of 70.0% compared with 80.0% in the control cohort.

Persistent infertility rates also showed a notable disparity between the two groups. The endometriosis cohort reached 30.0% for persistent infertility, while the control cohort stood at 20.0%. Early pregnancy loss figures followed a similar pattern, registering 16.0% in the endometriosis group versus 9.2% in controls.

Within the endometriosis cohort itself, the presence of concurrent chronic endometritis worsened reproductive metrics further. Patients with both conditions experienced a clinical pregnancy rate of 56.0%, compared with 76.0% for those with endometriosis alone.

Persistent infertility within the dual-condition subgroup reached 44.0%, while early pregnancy loss climbed to 31.0%. By comparison, patients with endometriosis alone recorded a 24.0% persistent infertility rate and an 11.3% early pregnancy loss rate.

Study Design Limits Conclusions and Calls for Prospective Research

Researchers emphasized that the cross-sectional design cannot establish causality or the temporal sequence between endometriosis and chronic endometritis. The reported reproductive outcomes were exploratory and unadjusted.

The dataset relied entirely on single-center retrospective electronic medical records from October 2019 to December 2024. Consequently, the findings remain insufficient to support universal diagnostic or therapeutic guidelines.

Future prospective investigations are required to determine whether treating concurrent chronic endometritis improves pregnancy rates in patients with endometriosis. Additional multicenter trials will also test the validity of these observational associations across broader populations.

Frequently Asked Questions About Endometriosis and Endometritis

How are endometriosis and chronic endometritis diagnosed simultaneously? Clinicians utilize a combination of laparoscopy, hysteroscopy, and endometrial biopsy, followed by cluster of differentiation 38 and cluster of differentiation 138 immunohistochemistry to identify plasma cells.

What was the sample size of the primary retrospective study? The research evaluated 1,000 total patients, comprising an endometriosis cohort of 250 individuals and a control cohort of 750 patients with tubal-factor infertility.

When was the Medicine study published? The observational study was published on October 30, 2026, in volume 105 of the journal.